|
DONSON expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.018300E-04 |
| Normal-vs-Stage3 |
9.0167999999835E-07 |
| Normal-vs-Stage4 |
3.916500E-03 |
| Stage1-vs-Stage2 |
4.663800E-01 |
| Stage1-vs-Stage3 |
4.894100E-02 |
| Stage1-vs-Stage4 |
1.163820E-01 |
| Stage2-vs-Stage3 |
6.077400E-01 |
| Stage2-vs-Stage4 |
2.516200E-01 |
| Stage3-vs-Stage4 |
3.694600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.86940035568273E-10 |
| Normal-vs-Asian |
9.195800E-03 |
| Caucasian-vs-AfricanAmerican |
9.676400E-01 |
| Caucasian-vs-Asian |
1.088770E-01 |
| AfricanAmerican-vs-Asian |
1.616420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
4.2721381987576E-13 |
| Male-vs-Female |
4.445400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.20420000216637E-08 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
4.5484727095868E-12 |
| Normal-vs-Extreme_Obese |
1.591660E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.804200E-01 |
| Normal_Weight-vs-Obese |
3.696600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.614200E-01 |
| Extreme_Weight-vs-Obese |
1.052170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.284800E-01 |
| Obese-vs-Extreme_Obese |
1.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.71449999999807E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.640600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.613600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.014380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.240700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.480190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.390180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.296000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
4.24290000022864E-07 |
| Normal-VS-KIRP CIMP |
2.49829999998674E-06 |
| Normal-VS-Unclassified PRCC |
1.41589999946845E-07 |
| Type1 PRCC-VS-Type2 PRCC |
6.779100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.87849957811181E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
1.076020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.5742003214383E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
3.349400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.95090002328169E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63419999754666E-09 |
| Normal-vs-N1 |
1.37230000030186E-07 |
| Normal-vs-N2 |
1.936620E-01 |
| N0-vs-N1 |
2.619500E-03 |
| N0-vs-N2 |
4.523400E-01 |
| N1-vs-N2 |
4.332400E-01 |
|
|
